Moderators:
Search This Board: 
Created: 08/09/2002 06:25:23 PM - Followers: 184 - Board type: Free - Posts Today: 0






Business Description

Provectus Biopharmaceuticals is investigating new therapies for the treatment of skin cancer and liver cancer. Provectus investigational oncology drug, PV-10, is an ablative immunotherapy under investigation in solid tumor cancers. The Company has received orphan drug designations from the FDA for its melanoma and hepatocellular carcinoma indications. PH-10, its topical investigational drug for dermatology, is undergoing clinical testing for psoriasis and atopic dermatitis. Provectus has completed Phase 2 trials of PV-10 as a therapy for metastatic melanoma, and of PH-10 as a topical treatment for psoriasis. In addition, Provectus has begun a Phase 3 trial as a therapy for metastatic melanoma. Information about these and the Company's other clinical trials can be found at the NIH registry, www.clinicaltrials.gov. For additional information about Provectus, please visit the Company's website at www.provectusbio.com.

The red synthetic dye Rose Bengal is shown in a bottle at Provectus Pharmaceuticals, Inc.


 


CURRENT PVCT PIPELINE (as of May 23, 2017)

--------------------------------------------------------------

Charts and Technical:

PVCT 6 months chart:
http://stockcharts.com/h-sc/ui?s=PVCT&p=D&yr=0&mn=6&dy=0&id=p03754661229

Technical analysis:
http://www.stockta.com/cgi-bin/analysis.pl?symb=PVCT&num1=7&cobrand=&mode=stock

PVCT News and Analysis:

PVCT News Blog with the latest news and analysis:

http://provectuspharmaceuticalsinc.blogspot.ca/p/news.html 

CONNECTING THE DOTS - CURRENT NEWS PAGE
http://provectuspharmaceuticalsinc.blogspot.ca/p/current-news_22.html

CONNECTING THE DOTS - BLOG PAGE

http://provectuspharmaceuticalsinc.blogspot.ca/


PVCT News at OTC 
http://www.otcmarkets.com/stock/PVCT/news

CLINICAL TRIALS Updates and Info:

FOR PV-10 CLINICAL TRIALS:
https://clinicaltrials.gov/ct2/results?term=PV-10&Search=Search

FOR PH-10 CLINICAL TRIALS:
https://clinicaltrials.gov/ct2/results?term=PH-10&Search=Search

PVCT insiders transactions:
http://www.secform4.com/insider/showhistory.php?symbol=pvct



For Clinical Trials and Compassionate Use Programs, Investor Information including SEC filing and Corporate Presentations, Press and Media Releases, and Contact information:
http://www.pvct.com/index.html

PVCT on YouTube...
http://www.youtube.com/watch?v=nuYpvcnAq4c

------------------------------------------------------------

Contact Info:

Telephone: (866) 594-5999
info@pvct.com
scott@pvct.com

Mailing Address:

Provectus Pharmaceuticals, Inc.
7327 Oak Ridge Hwy
Knoxville, TN 37931 USA

--------------------------------------------------------------

PVCT Share Structure
Market Value:  $18,517,732 a/o May 04, 2017
Authorized Shares:  1,000,000,000  a/o Apr 30, 2017
Outstanding Shares:  370,354,643  a/o Apr 30, 2017
-Restricted:  N/A
-Unrestricted:  N/A
Held at DTC: N/A
Float:  75,807,312  a/o Jun 30, 2016
Par Value:  0.001
Transfer Agent  Broadridge Financial Solutions, Inc.
Shareholders of Record:  972 a/o Mar 31, 2017
Short Selling Data
Short Interest 167,323 (69.16%)
Apr 13, 2017
Significant Failures to Deliver No





Insider Shares:
http://www.nasdaq.com/symbol/pvct/insider-trades

Institutional Ownership:
http://www.nasdaq.com/symbol/pvct/institutional-holdings

--------------------------------------------------------------

10Q Filed May 10, 2017:


https://ih.advfn.com/p.php?pid=nmona&article=74554789

8K Filed June 1, 2017; Board elected, no share increase

http://ih.advfn.com/p.php?pid=nmona&article=74843932&symbol=PVCT

8K filed August 1, 2017; Provectus Biopharmaceuticals, Inc. is entitled to receive total damages of $6,027,652

http://ih.advfn.com/p.php?pid=nmona&article=75359078

8K filed October 18, 2917; Provectus announces results from the Company’s ongoing Phase 1b/2 study of IL PV-10 in combination with KEYTRUDA® (pembrolizumab)

https://www.sec.gov/Archives/edgar/data/315545/000149315217011744/ex99-1.htm
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
PlusOneCoin Top Posts Free PlusOneCoin
No plusone'd posts yet. Be the first!
Post Subject
#9821
NEWS -- Provectus Biopharmaceuticals Presents Data from PV-10® Paulness 06/30/2022 05:40:17 PM
#9820
NEWS -- Provectus Biopharmaceuticals Announces Stockholder Approval to Paulness 06/23/2022 04:03:08 PM
#9819
NEWS -- Provectus Biopharmaceuticals Presents Multiple Metabolic Complete Paulness 06/08/2022 09:06:42 AM
#9818
Do you believe co if they put proposal kentstate12 06/03/2022 01:32:11 PM
#9817
Has the announcement of a reverse split changed kentstate12 06/03/2022 01:10:23 PM
#9816
NEWS -- PVCT Quarterly Report (10-Q) Paulness 05/12/2022 02:43:46 PM
#9815
NEWS -- Provectus Biopharmaceuticals Announces Notice of Allowance Paulness 05/03/2022 04:02:50 PM
#9814
NEWS -- Provectus Biopharmaceuticals Announces Acceptance of PV-10® Paulness 04/27/2022 02:51:29 PM
#9813
NEWS -- Provectus Biopharmaceuticals Announces Notice of Allowance Paulness 04/26/2022 09:36:08 AM
#9812
NEWS -- Provectus Biopharmaceuticals Seeks Stockholder Approval at Paulness 04/19/2022 06:55:43 PM
#9811
This has always been an obvious scam.. How SpaceTimeRift777 04/17/2022 07:25:37 PM
#9810
NEWS -- Provectus Biopharmaceuticals Names Aru Narendran, MD, Paulness 04/14/2022 08:52:52 AM
#9809
NEWS -- Provectus Biopharmaceuticals Announces Presentation of Multiple Paulness 04/11/2022 07:50:12 AM
#9808
NEWS -- Provectus Biopharmaceuticals Announces Synthesis of New Paulness 03/24/2022 08:25:14 AM
#9807
NEWS -- Provectus Biopharmaceuticals Announces Oral Presentation of Paulness 03/16/2022 09:44:28 AM
#9806
NEWS -- Provectus Biopharmaceuticals Announces Acceptance of PV-10® Paulness 02/16/2022 09:14:18 AM
#9805
NEWS -- Provectus Biopharmaceuticals Announces Acceptance of PV-10® Paulness 02/08/2022 08:46:39 AM
#9804
Although still a long shot, and far from Plegee 02/01/2022 08:50:17 PM
#9803
NEWS -- Provectus Biopharmaceuticals Announces Acceptance of PV-10® Paulness 02/01/2022 07:41:39 AM
#9802
NEWS -- Provectus Biopharmaceuticals Provides Update on Research Paulness 01/27/2022 10:34:49 AM
#9801
Excuse me But doesn’t this appear to be fantastic McMagyar 01/11/2022 09:45:17 AM
#9800
NEWS -- Provectus Biopharmaceuticals Announces Publication of Pharmaceutical- Paulness 01/10/2022 08:12:16 AM
#9799
https://www.mdpi.com/1420-3049/27/1/322?fbclid=IwAR0yGl6C_Odu2Pfg9dHcw8nGivinWk6 Paulness 01/07/2022 11:26:54 PM
#9798
I wish to read up on the liver thefamilyman 11/01/2021 10:46:15 AM
#9797
NEWS -- Provectus Biopharmaceuticals Announces Presentation of Meta-Analysis Paulness 11/01/2021 08:28:57 AM
#9796
Company has promise, no doubt about that. Plegee 10/28/2021 10:41:06 AM
#9795
NEWS -- Provectus Biopharmaceuticals Announces Presentation of Updated Paulness 10/28/2021 08:30:24 AM
#9794
NEWS -- Provectus Biopharmaceuticals Provides Update on Research Paulness 10/04/2021 10:56:37 AM
#9793
NEWS -- Provectus Biopharmaceuticals Announces Acceptance of PV-10 Paulness 09/27/2021 08:19:15 AM
#9792
NEWS -- Provectus Biopharmaceuticals Announces Presentation of Full Paulness 09/21/2021 08:58:38 AM
#9791
Never happen until the warrants are gone end happy gylmore 08/10/2021 12:56:30 PM
#9790
Finally broke above .07... felt like we were formerdtrader 08/09/2021 03:18:54 PM
#9789
NEWS -- Provectus Biopharmaceuticals Announces Acceptance of PV-10® Paulness 07/19/2021 07:20:42 AM
#9788 NEWS -- Provectus Biopharmaceuticals Announces Publication of In Paulness 06/09/2021 09:03:55 AM
#9787 NEWS -- Provectus Biopharmaceuticals Announces Presentation of Full Paulness 06/04/2021 09:26:56 AM
#9786 NEWS -- State of Tennessee Awards Funding for Paulness 05/25/2021 09:05:01 AM
#9785 Warrant overhang. 14 more weeks and they expire. happy gylmore 04/30/2021 02:30:52 PM
#9784 NEWS -- Provectus Biopharmaceuticals Announces Acceptance of PV-10® Paulness 04/28/2021 05:12:27 PM
#9783 never seen a company with more good news formerdtrader 04/02/2021 03:35:46 PM
#9782 NEWS -- Provectus Biopharmaceuticals Announces Publication of Australian Paulness 03/31/2021 08:24:05 AM
#9781 NEWS -- Provectus Biopharmaceuticals Receives Notice of Allowance Paulness 03/30/2021 07:53:11 AM
#9780 NEWS -- Provectus Biopharmaceuticals Receives Notice of Allowance Paulness 03/23/2021 09:16:29 AM
#9779 more good news today as the company keeps formerdtrader 03/23/2021 08:53:42 AM
#9778 Mark could use some good news McMagyar 01/25/2021 06:44:46 PM
#9777 Thanks FDT! I've put it on my watch slambino 01/24/2021 02:33:46 PM
#9776 Yes Slambino, just a hope formerdtrader 01/24/2021 12:18:29 PM
#9775 Is that a random hope, or are they slambino 01/23/2021 03:12:32 PM
#9774 NEWS -- Provectus Biopharmaceuticals Announces Release of Preprint Paulness 01/20/2021 08:01:30 AM
#9773 NEWS -- Provectus Biopharmaceuticals Announces Oral Presentation of Paulness 12/07/2020 08:49:11 AM
#9772 NEWS -- Provectus Biopharmaceuticals Announces Presentation of PV-10® Paulness 11/16/2020 07:48:15 AM
Post Subject